cho_logo_symbol_border
  • (800) 266-7207 | 30 Wall St. 8th Floor New York, NY 10005
  • Mon - Fri: 8:00 am - 5:00 pm

News

How to Protect Yourself & Others
Protect Unvaccinated Family Members Some people in your family need to continue to take steps to protect themselves from COVID-19,
Beyond the Pandemic: Confronting the Triple Menace of COVID-19, Flu, and RSV with Innovative Testing Solutions
Discover how artificial intelligence and advanced lab-developed tests are poised to transform our understanding, testing, and treatment of future variants
Unseen Casualties of the Pandemic: How COVID-19 Led to Thousands of Missed Prostate Cancer Diagnoses in England
The Covid-19 pandemic, with its mishandling and resultant chaos, has left a trail of unseen tragedies, particularly in healthcare. A
Chronic Anxiety
Unmasking Chronic Anxiety’s 95% Misdiagnosis Rate & Need for Precision Beyond Self-Recognition
Many of us experience worry, fear, and physical symptoms like a racing heart. While these are often fleeting responses to
Essential Knowledge about Prostate Cancer for Patients
The recent diagnosis of prostate cancer in notable figures like Ryne Sanberg, a Chicago Cubs Hall of Fame player, and
Clear Health Pass Revolutionizing Preventive Care with Ethical AI
Empowering Health Advocates: How Clear Health Pass is Revolutionizing Preventive Care with Ethical AI
  In an era where healthcare is increasingly personalized and data-driven, Clear Health Pass (CHP) emerges as a beacon of
Medical Ethics and AI: Safeguarding Your Genomic Code
AI Medical Ethics: Safeguarding Your Genomic Code
Artificial intelligence (AI) presents a groundbreaking frontier in healthcare, offering unprecedented capabilities in analyzing vast datasets, including our own genomic
Revolutionary AI Predicts Alzheimer’s 7 Years Early: A UCSF Breakthrough
  Researchers at the University of California, San Francisco, have achieved a medical milestone by using artificial intelligence to predict
Toxicology Drug Screening Market Towards a $70.8 Billion Valuation by 2033
The market for global toxicology drug screening is projected to witness significant growth, with expectations to reach a value of
The Hidden Danger in the Air: How Fine Particulate Matter is Impacting Our Health
Recent studies in the United States have uncovered a worrying link between both short-term and long-term exposure to fine particulate
The Importance of Prompt Detection in Combating Childhood Cancer
Experts agree that prompt detection plays a pivotal role in combatting childhood cancer. Identifying cancer in its initial stages not

Disclaimer

Clear Health Pass Safe Harbor Exemption
The information on this website does not constitute an offer to sell or solicitation of an offer to buy securities by anyone in any jurisdiction which would be considered unlawful. Clear Health Pass Holdings, LLC’s offering is under Rule 506(c) of Regulation D and is considered a “safe harbor” for the private offering exemption of Section 4(a)(2) of the Securities Act. To be eligible to receive qualified investment status, you must be an accredited investor as defined by Section 2(15)(ii) of the Securities Act of 1933.

© 2023 Clear Health Pass Holdings™, LLC., All trademark references are trademarks of either the Clear Health Pass Holdings, LLC or their respective owners.

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $20,000,000

Funding Goal $20,000,000

20%

Click here to Download Our Investment Package

Skip to content